OLI recorded this information on 11/29/2017
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the Board of Directors has increased the company's quarterly dividend to $0.48 per outstanding share of the company's common stock, up $0.01 from $0.47 per outstanding share paid last quarter. Payment will be made on Jan. 8, 2018, to stockholders of record at the close of business on Dec. 15, 2017. The Board also authorized an additional $10 billion of treasury stock purchases with no time limit for completion.
Merck & Co. is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. Co.'s segments are: Pharmaceutical, which includes human health pharmaceutical products that consist of therapeutic and preventive agents for the treatment of human disorders, and human health vaccine products that consist of preventive pediatric, adolescent and adult vaccines; and Animal Health, which discovers, develops, manufactures and markets veterinary pharmaceuticals, vaccines and health management solutions and services, as well as a suite of digitally connected identification, traceability and monitoring products.
Merck SEC Filing Email Alerts Service
Open the MRK Page at The Online Investor »
Strong Buy (3.54 out of 4)